150 Western Ave
7 articles about Harvard University
Artificial intelligence identifies anti-aging drug candidates targeting ‘zombie’ cells
Integrated Biosciences in collaboration with researchers at the Massachusetts Institute of Technology and the Broad Institute of MIT and Harvard, announced results demonstrating the power of artificial intelligence to discover novel senolytic compounds, a class of small molecules under intense study for their ability to suppress age-related processes such as fibrosis, inflammation and cancer.
Harvard scientists believe they've uncovered one of the primary drivers of aging, and it isn’t DNA mutation. A study published Thursday points to epigenetics as the key.
Newly-launched Massachusetts biomanufacturing facility will be something like a conveyor belt from the academic bench to the early startup.
A new discovery related to the mechanism of the danger signal adenosine triphosphate could influence how immunomodulators, such as vaccines and allergy medications, are formulated.
BioSpace looks at the challenges faced by the Latinx community in the life sciences, from the origins of the challenges, to educational gain and the importance of mentorship.
Here's a look at some of this week's most interesting research news.
A former Harvard University professor of ophthalmology has retracted eight research paper abstracts published in professional journals over ethics concerns.